A prospective, randomized, single- blind, controlled study to investigate the effect of suplatast tosilate on early- stage idiopathic pulmonary fibrosis
Phase 3
- Conditions
- Idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000001567
- Lead Sponsor
- Hiroshima University Hospital, Department of Respiratory Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who cannot carry out pulmonary function test 2. Patients whose causes for interstitial pneumonia are apparent. 3. Patients who participated in a clinical trial within the past three months 4. Patients who contraindicate for suplatast tosilate. 5. Patients who are judged to be unfit for the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary function test
- Secondary Outcome Measures
Name Time Method Six-minute walk distance Serum markers (KL-6,SP-D,SP-A) Radiological findings Subjective symptoms Safety